A vaccine jointly developed by Pfizer and BioNTech was 90 percent effective in preventing Covid-19 infections in ongoing Phase 3 trials, the companies announced Monday. The statement was released as…
Read More COVID-19 vaccine 90% effective in Phase 3 trial, says Pfizer
The American biopharmaceutical company, Pfizer has announced that its coronavirus vaccine could be ready for emergency use by September. The testing of the experimental vaccine in the US, the company…
Read More COVID-19 vaccine may be ready by September, says Pfizer
